Matrix metalloproteinases (MMPs) are associated with the alteration of extracellular matrix. The purpose of this study was to investigate how the levels of matrix metalloproteinases and their inhibitors - TIMPs are influenced by the presence of inguinal hernia as well as by its surgical treatment. The studied group consisted of 25 patients with inguinal hernia and 21 healthy controls for comparison. Two blood samples - before and after the treatment were collected from patients. Serum concentrations of MMPs and TIMPs were analysed by multiplex immunoassays. There was a difference in circulating levels of MMPs in patients before the surgery compared to healthy controls - the concentrations of MMP-2 and MMP-9 were significantly lower (p=0.026, p=0.018, respectively). After the surgery, the levels of MMPs, especially MMP-2 (p<0.0001), were significantly decreased in patients compared to the preoperative values, apart from MMP-9. On the contrary, MMP-9 showed significant increase after the surgery (p<0.0001). Circulation levels of TIMP-2 in patients were significantly decreased in comparison with controls (p=0.004), whereas levels of TIMP-1 were similar to controls. Both tested metalloproteinase inhibitors showed a significant decrease in detected levels (TIMP-1 p=0.0004; TIMP-2 p<0.0001) after the procedure compared to the preoperative values. The levels of MMPs, especially MMP-2 and MMP-9, and their inhibitors TIMP-1 and TIMP-2 are involved by the presence of inguinal hernia as well as are influenced by the surgery.

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Zobrazit více v PubMed

ALDONYTE R, BRANTLY M, BLOCK E, PATEL J, ZHANG J. Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells. Exp Lung Res. 2009;35:59–75. doi: 10.1080/01902140802406059. PubMed DOI

ANTONIOU GA, TENTES IK, ANTONIOU SA, SIMOPOULOS C, LAZARIDES MK. Matrix metalloproteinase imbalance in inguinal hernia formation. J Invest Surg. 2011;24:145–150. doi: 10.3109/08941939.2011.558610. PubMed DOI

ANTONIOU SA, ANTONIOU GA, GRANDERATH FA, SIMOPOULOS C. The role of matrix metalloproteinases in the pathogenesis of abdominal wall hernias. Eur J Clin Invest. 2009;39:953–959. doi: 10.1111/j.1365-2362.2009.02199.x. PubMed DOI

BELLÓN JM, BAJO A, GA-HONDUVILLA N, GIMENO MJ, PASCUAL G, GUERRERO A, BUJÁN J. Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg. 2001;233:287–291. doi: 10.1097/00000658-200102000-00020. PubMed DOI PMC

CAUWE B, VAN DEN STEEN PE, OPDENAKKER G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol. 2007;42:113–185. doi: 10.1080/10409230701340019. PubMed DOI

CUADRADO E, ROSELL A, BORRELL-PAGES M, GARCIA-BONILLA L, HERNANDEZ-GUILLAMON M, ORTEGA-AZNAR A, MONTANER J. Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia. J Cereb Blood Flow Metab. 2009;29:398–410. doi: 10.1038/jcbfm.2008.130. PubMed DOI

DABBAS N, ADAMS K, PEARSON K, ROYLE G. Frequency of abdominal wall hernias: is classical teaching out of date? JRSM Short Reports. 2011;2:5. doi: 10.1258/shorts.2010.010071. PubMed DOI PMC

GILL SE, PARKS WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol. 2008;40:1334–1347. doi: 10.1016/j.biocel.2007.10.024. PubMed DOI PMC

HENRIKSEN NA, MORTENSEN JH, SORENSEN LT, BAY-JENSEN AC, AGREN MS, JORGENSEN LN, KARSDAL MA. The collagen turnover profile is altered in patients with inguinal and incisional hernia. Surgery. 2015;157:312–321. doi: 10.1016/j.surg.2014.09.006. PubMed DOI

HENRIKSEN NA, YADETE DH, SORENSEN LT, AGREN MS, JORGENSEN LN. Connective tissue alteration in abdominal wall hernia. Br J Surg. 2011;98:210–219. doi: 10.1002/bjs.7339. PubMed DOI

HOLZHEIMER RG. Inguinal Hernia: classification, diagnosis and treatment--classic, traumatic and Sportsman’s hernia. Eur J Med Res. 2005;10:121–134. PubMed

ISIK A, GURSUL C, PEKER K, AYDIN M, FIRAT D, YILMAZ I. Metalloproteinases and their inhibitors in patients with inguinal hernia. World J Surg. 2017;41:1259–1266. doi: 10.1007/s00268-016-3858-6. PubMed DOI

JABŁOŃSKA-TRYPUĆ A, MATEJCZYK M, ROSOCHACKI S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enz Inhib Med Chem. 2016;31:177–183. doi: 10.3109/14756366.2016.1161620. PubMed DOI

JIANG ZP, YANG B, WEN LQ, ZHANG YC, LAI DM, LI YR, CHEN S. The etiology of indirect inguinal hernia in adults: congenital or acquired? Hernia. 2015;19:697–701. doi: 10.1007/s10029-014-1326-5. PubMed DOI

KLINGE U, ZHENG H, SI Z, SCHUMPELICK V, BHARDWAJ RS, MUYS L, KLOSTERHALFEN B. Expression of the extracellular matrix proteins collagen I, collagen III and fibronectin and matrix metalloproteinase-1 and -13 in the skin of patients with inguinal hernia. Eur Surg Res. 1999;31:480–490. doi: 10.1159/000008728. PubMed DOI

KWAN JA, SCHULZE CJ, WANG W, LEON H, SARIAHMETOGLU M, SUNG M, SAWICKA J, SIMS DE, SAWICKI G, SCHULZ R. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J. 2004;18:690–692. doi: 10.1096/fj.02-1202fje. PubMed DOI

LEE MH, MURPHY G. Matrix metalloproteinases at a glance. J Cell Sci. 2004;117:4015–4016. doi: 10.1242/jcs.01223. PubMed DOI

LI J, ZHANG X, SUN Q, LI W, YU A, FU H, CHEN K. Circulating matrix metalloproteinases and procollagen propeptides in inguinal hernia. Hernia. 2018;22:541–547. doi: 10.1007/s10029-018-1751-y. PubMed DOI

LIMB GA, MATTER K, MURPHY G, CAMBREY AD, BISHOP PN, MORRIS GE, KHAW PT. Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis. Am J Pathol. 2005;166:1555–1563. doi: 10.1016/S0002-9440(10)62371-1. PubMed DOI PMC

LUO D, MARI B, STOLL I, ANGLARD P. Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase. J Biol Chem. 2002;277:25527–25536. doi: 10.1074/jbc.M202494200. PubMed DOI

PEETERS E, DE HERTOGH G, JUNGE K, KLINGE U, MISEREZ M. Skin as marker for collagen type I/III ratio in abdominal wall fascia. Hernia. 2014;18:519–525. doi: 10.1007/s10029-013-1128-1. PubMed DOI

RAMANAN B, MALOLEY BJ, FITZGIBBONS RJ., Jr Inguinal hernia: follow or repair? Adv Surg. 2014;48:1–11. doi: 10.1016/j.yasu.2014.05.017. PubMed DOI

ROSENBERG GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 2009;8:205–216. doi: 10.1016/S1474-4422(09)70016-X. PubMed DOI

ROY R, YANG J, MOSES MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27:5287–5297. doi: 10.1200/JCO.2009.23.5556. PubMed DOI PMC

SMIGIELSKI J, BROCKI M, KUZDAK K, KOŁOMECKI K. Serum MMP 2 and TIMP 2 in patients with inguinal hernias. Eur J Clin Invest. 2011;41:584–588. doi: 10.1111/j.1365-2362.2010.02445.x. PubMed DOI

SMIGIELSKI J, KOŁOMECKI K, ZIEMNIAK P, DROZDA R, AMSOLIK M, KUZDAK K. Degradation of collagen by metalloproteinase 2 in patients with abdominal hernias. Eur Surg Res. 2009;42:118–121. doi: 10.1159/000187643. PubMed DOI

WANG D, HAN Y, XU X, CHEN J, CHEN Y. Matrix Metalloproteinases (MMP-2) and Tissue Inhibitors of Metalloproteinases (TIMP-2) in Patients with Inguinal Hernias. World J Surg. 2020 doi: 10.1007/s00268-020-05674-0. PubMed DOI

ZÖLLER B, JI J, SUNDQUIST J, SUNDQUIST K. Shared and nonshared familial susceptibility to surgically treated inguinal hernia, femoral hernia, incisional hernia, epigastric hernia, and umbilical hernia. J Am Coll Surg. 2013;217:289–299.e281. doi: 10.1016/j.jamcollsurg.2013.04.020. PubMed DOI